Barclays (LON:BARC) initiated coverage on Natera shares (NASDAQ:NTRA), currently trading at $171.93, with an Overweight rating and a $200 price target. The stock has demonstrated remarkable momentum,

Barclays PLC bought a new stake in shares of Genasys Inc. (NASDAQ:GNSS – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 19,680 shares of the company’s stock,

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other AI stocks. Insights on AI’s Potential and Its Evolving Capabilities AI is rapidly advancing,

Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating and setting a price target of $70.

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Relay Therapeutics Inc (NASDAQ:RLAY) stands against the other medical AI stocks.

Barclays PLC boosted its position in Nayax Ltd. (NASDAQ:NYAX – Free Report) by 5,526.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 2,307 shares of the company’s stock after purchasing an additional 2,

Barclays (LON:BARC) began coverage on Guardant Health (NASDAQ:GH) shares, assigning an Overweight rating and setting a price target of $60. The new outlook comes as Guardant Health, a precision oncology company,

We recently compiled a list of the 10 AI News You Probably Missed. In this article, we are going to take a look at where Lumentum Holdings Inc. (NASDAQ:LITE) stands against the other AI stocks. AI Boosts Data Center Market to New Heights According to Synergy Research Group,

The S&P500 (SP500) closed in the red on Friday, after the week witnessed new policies from U.S. President Donald Trump, along with earnings reports from many financial and tech companies. For the week,

The Nasdaq led gains among Wall Street's main indexes on Wednesday, as investors cheered streaming giant Netflix's strong quarterly performance and President Donald Trump's multi-billion dollar support to bolster AI infrastructure.

Barclays (LON:BARC) adjusted the firm's stance on Netflix (NASDAQ:NFLX) stock, upgrading it from Underweight to Equalweight with a new price target of $900, a significant increase from the previous $715.

This article looks at three stocks with solid insider and institutional buying in Q4 2024 and determines whether they are suitable for 2025.  B&G Foods: High-Yielding Consumer Staple Has Risks B&G Foods (NYSE: BGS) is a small-cap consumer staple with an extensive portfolio of brands.